NCT03329417

Brief Summary

In the proposed study, the investigators assumed that mirror therapy combined with virtual reality technology will provide a better treatment effects than traditional mirror therapy for the patients with unilateral stroke. The aim of the study is to examine the difference in the treatment effects among the combination of task-oriented training with either virtual reality based mirror therapy, mirror therapy or traditional occupational therapy on the upper extremity function and brain activity of the stroke patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
134

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 30, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 6, 2017

Completed
7 days until next milestone

Study Start

First participant enrolled

November 13, 2017

Completed
6.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2024

Completed
Last Updated

March 21, 2024

Status Verified

March 1, 2023

Enrollment Period

6.4 years

First QC Date

October 30, 2017

Last Update Submit

March 20, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Change in the result of Fugl-Meyer assessment (FMA) for motor function of upper extremity test

    Each item is rated on a three-point ordinal scale (2 points for the detail being performed completely, 1 point for the detail being performed partially, and 0 for the detail not being performed). The maximum motor performance score is 66 points for the upper extremity.

    baseline, 6 weeks and 18 weeks

  • Change in the result of Modified Ashworth scale (MAS)

    Muscle tone is defined by the resistance of a muscle being stretched without resistance. The MAS scores were distributed across the entire scale, ranging from 0 to 4, that is convenient for the clinician use. The grading of the scale is described as below: 0) no increase in muscle tone; 1) minimal resistance at the end of the range of motion; 1+) slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the reminder (less than half) of the ROM; 2) more marked increase in tone but only after part is easily flexed; 3) considerable increase in tone; and 4) passive movement is difficult and affected part is rigid in flexion or extension.

    baseline, 6 weeks and 18 weeks

  • Change in the result of Box and blocks test

    The score is the number of blocks carried from one box to the other in one minute. Higher values represent a better outcome.

    baseline, 6 weeks and 18 weeks

  • Change in the result of Semmes-Weinstein monofilament (SWM) test

    The Semmes-Weinstein monofilamenttest examines the cutaneous pressure threshold, range from 1.65-6.65. Higher values represent a worse outcome.

    baseline, 6 weeks and 18 weeks

  • Change in the result of Motor Activity Log

    Semi-structured interview examine how much and how well the subject uses their more-affected arm for 30 ADLs. Score range from 0-180. Higher values represent a better outcome.

    baseline, 6 weeks and 18 weeks

Secondary Outcomes (2)

  • Change in Power Spectrum of the Electroencephalography (EEG)

    baseline and 6 weeks

  • Changes in Cortical Excitability Assessed by Transcranial Magnetic Stimulation

    baseline and 6 weeks

Study Arms (3)

Traditional occupational therapy

ACTIVE COMPARATOR

The program includes 30 minutes of traditional occupational therapy (sensorimotor facilitation techniques, such as: Rood, Bobath and propriocetive-neuromuscular-facilitation), followed by 20 minutes of motor task specific training in each treatment session.

Other: task-oriented training

Mirror therapy using a mirror box

ACTIVE COMPARATOR

The program includes 30 minutes of mirror therapy, followed by 20 minutes of regular motor task specific training in each treatment session.

Other: task-oriented training

Virtual reality based mirror therapy

EXPERIMENTAL

The program includes 30 minutes treatment session of virtual reality mirror therapy, followed by 20 minutes of motor task specific training in each treatment session.

Other: task-oriented training

Interventions

Motor training targeted to goals that are relevant to the functional needs of the patient

Mirror therapy using a mirror boxTraditional occupational therapyVirtual reality based mirror therapy

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of stroke with unilateral side involved;
  • A score of Mini-mental state examination greater than 24 for proving higher mental function;
  • Time of onset \> 6 months before treatment begins, and
  • Premorbid right-handedness.

You may not qualify if:

  • Vision loss;
  • Major cognitive-perceptual deficit;
  • Other brain disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cheng-Kung University Hospital

Tainan, 704, Taiwan

Location

Related Publications (1)

  • Hsu HY, Kuo LC, Lin YC, Su FC, Yang TH, Lin CW. Effects of a Virtual Reality-Based Mirror Therapy Program on Improving Sensorimotor Function of Hands in Chronic Stroke Patients: A Randomized Controlled Trial. Neurorehabil Neural Repair. 2022 Jun;36(6):335-345. doi: 10.1177/15459683221081430. Epub 2022 Mar 28.

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 30, 2017

First Posted

November 6, 2017

Study Start

November 13, 2017

Primary Completion

March 20, 2024

Study Completion

March 20, 2024

Last Updated

March 21, 2024

Record last verified: 2023-03

Locations